12.11.23 Ward notes
Pacemaker infections
Sites
Lung abscess
Under skin
Endocarditis
Management
Prognostic symptoms in AS
Factors
Aortic jet velocity
Mean gradient
Aortic valve area
Mortality rates from the onset of symptoms are approximately 25% at 1 year and 50% at 2 years
More than 50% of deaths are sudden
Mortality breakdown (without surgery):
CHF : 2 year mortality = 50%
Combination of systolic dysfunction (a decrease in the ejection fraction) and diastolic dysfunction (elevated filling pressure of the LV)
Syncope : 3 year mortality = 50%
Unable to increase output?
Vasodepressor response from high LV pressure?
Coronary artery insufficiency?
Calcification leading to heart block or arrhythmia?
Angina : 5 year mortality = 50%
Secondary to LVH
Surgical treatments for AF
Aortic Valve Replacement
In most adults with symptomatic, severe aortic stenosis, aortic valve replacement is the surgical treatment of choice
If concomitant coronary disease is present, aortic valve replacement and coronary artery bypass graft (CABG) should be performed simultaneously
Aortic valve replacement should be performed in all symptomatic patients with severe aortic stenosis, regardless of LV function, as survival is better with surgical treatment than with medical treatment
Aortic valve replacement is also recommended in asymptomatic patients with severe aortic stenosis and LV dysfunction
Improvement in EF invariably occurs over the following 6 months, and increased LV mass tends to decrease within 18 months postoperatively
Bioprosthetic vs mechanical valves
The choice of prosthesis is determined by the anticipated longevity of the patient and his/her ability to tolerate anticoagulation
Surgical mortality risk in patients with normal LV systolic function and no other comorbid conditions is less than 5%
Overall, the 5-year survival rate in all adults after aortic valve replacement is 80-94%, and the 10-year survival rate is 68-89%
Ross procedure
Another option in young patients as an initial procedure or for reoperation after prior valvotomy
The patient's own pulmonary valve and main pulmonary artery are transplanted to the aortic position, with reimplantation of coronary arteries
A homograft is placed in the pulmonary position
The Ross procedure is technically demanding and results at different centers have been mixed.
Percutaneous transcatheter valve replacement
Percutaneous transcatheter aortic-valve replacement (TAVR) with a balloon-expandable bovine pericardial valve is a less invasive option for these high-risk patients
Used as a palliative measure in critically ill adult patients who are not surgical candidates or as a bridge to aortic valve replacement in critically ill patients
The high rate of restenosis and the absence of a mortality benefit preclude its use as a definitive treatment method in adults with severe aortic stenosis
JVP waveform
A wave
Right Atrial contraction
Ends synchronously with the carotid artery pulse
Peak demarcates the end of atrial systole
C wave
Right ventricular Contraction causing the triCuspid valve to bulge towards the right atrium
X descent
Corresponds to atrial relaXation and rapid atrial filling due to low pressure
X' descent
Occurs as a result of the right ventricle pulling the tricuspid valve downward during ventricular systole
Used as a measure of right ventricle contractility
V wave
Corresponds to Venous filling when the tricuspid valve is closed and venous pressure increases from venous return
Y descent
Corresponds to the rapid emptYing of the atrium into the ventricle following the opening of the tricuspid valve
Pemberton's sign
Raise both of the patient's arms above his/her head simultaneously, as high as possible
Positive sign = Development of facial flushing, distended neck and head superficial veins, inspiratory stridor and elevation of the JVP
Cause - Superior vena cava syndrome
Mass in the mediastinum
Goiter
JVP Waveform in AF
A waves completely absent
Notes
Ventricular systole is between the peak of the c and v waves